Related Experiment Videos
[The treatment results in hemangiomas in children under dispensary observation]
Stomatologiia
|January 1, 1993
Insights
Early detection and treatment of maxillofacial hemangiomas in infants at local health centers can prevent hospitalization. This approach allows for personalized treatment strategies and identification of infants likely to experience spontaneous regression.
Area of Science:
- Pediatric Oncology
- Dermatology
- Vascular Anomalies
Context:
- Maxillofacial hemangiomas are common benign vascular tumors in infants.
- Tumor growth can lead to functional and aesthetic complications.
- Timely intervention is crucial for optimal outcomes.
Purpose:
- To highlight the efficacy of early detection and management of infantile maxillofacial hemangiomas.
- To propose a strategy for non-hospitalized treatment and follow-up.
- To identify potential cases of spontaneous regression.
Summary:
- Infantile maxillofacial hemangiomas can be effectively managed in prophylactic health centers, avoiding hospital admission.
- Treatment strategies should be individualized based on hemangioma characteristics (shape, size, location).
- A cohort of patients exhibiting spontaneous regression can be identified and monitored.
Impact:
- Reduces the need for hospital-based treatments, lowering healthcare costs and patient burden.
- Enables tailored therapeutic approaches, improving treatment efficacy.
- Facilitates proactive monitoring of infants with hemangiomas, optimizing long-term results.
Abstract:
Maxillofacial hemangiomas in young infants can be effectively detected and treated at prophylactic health centers before the tumor progressively grows, this helping do without hospital treatment. Individual methods of treatment and the most rational strategy with due consideration for the tumor shape, size and site can be chosen and the group of patients with spontaneous regression singled out and followed up.